CTTH CTT Pharmaceutical (CTTH) Insider Trading, Ownership & Congress Trades
Pharma & Biotech · Pharmaceutical preparations · CIK 0001035422
C-suite buying · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about CTTH
Insiders, 180 days
+$4.6K net bought
1 buyer
CTT Pharmaceutical insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CTT PHARMACEUTICAL HOLDINGS, INC. insiders bought a net $4.6K of stock across 63 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-29.
Insider
Filed
Shares
Value
Since filing
Context
- 62 earlier Form 4 trades (code P or S) here by this insider (62 buys), the last on Oct 15, 2026.
- +25.0% median (+28.0% mean) 90-day return after 16 previous buys.
- The trade is 0.1% of the 9,442,536 shares held after it.
- No other insider bought within 30 days.
Insider activity: CEO CTT PHARMACEUTICAL HOLDINGS, INC. bought about $335 of CTTH on Oct 26, 2026.Context
- 61 earlier Form 4 trades (code P or S) here by this insider (61 buys), the last on Oct 6, 2026.
- +24.3% median (+24.8% mean) 90-day return after 17 previous buys.
- The trade is 0.0% of the 9,436,656 shares held after it.
- No other insider bought within 30 days.
Insider activity: CEO CTT PHARMACEUTICAL HOLDINGS, INC. bought about $114 of CTTH on Oct 15, 2026.Context
- 60 earlier Form 4 trades (code P or S) here by this insider (60 buys), the last on Sep 28, 2026.
- +23.0% median (+22.7% mean) 90-day return after 18 previous buys.
- The trade is 0.0% of the 9,433,656 shares held after it.
- No other insider bought within 30 days.
Insider activity: CEO CTT PHARMACEUTICAL HOLDINGS, INC. bought about $204 of CTTH on Oct 6, 2026.Context
- 59 earlier Form 4 trades (code P or S) here by this insider (59 buys), the last on Sep 22, 2026.
- +21.8% median (+21.5% mean) 90-day return after 19 previous buys.
- The trade is 0.0% of the 9,429,956 shares held after it.
- No other insider bought within 30 days.
Insider activity: CEO CTT PHARMACEUTICAL HOLDINGS, INC. bought about $187 of CTTH on Sep 28, 2026.Context
- 58 earlier Form 4 trades (code P or S) here by this insider (58 buys), the last on Sep 16, 2026.
- +23.0% median (+22.1% mean) 90-day return after 20 previous buys.
- The trade is 0.1% of the 9,424,556 shares held after it.
- No other insider bought within 30 days.
Insider activity: CEO CTT PHARMACEUTICAL HOLDINGS, INC. bought about $454 of CTTH on Sep 22, 2026.63 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$4.6K over 180 days
+$4.6K over 90 days
more than 64% of Pharma & Biotech
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
no share repurchases reported
Short interest
0.1% of the float short (float per yahoo 2026-10-27) · 1.3 days to cover · settled 2026-10-15
below 92% of Pharma & Biotech
What changed in the last 30 days
Oct 26CEO CTT PHARMACEUTICAL HOLDINGS, INC. bought $653 (3 trades, Oct 6 to Oct 26)
Watch CTTH
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-4.4%12M
Insider buy
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CTTH: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in CTTH
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CTTH planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $4.6K bought by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
CTTH Stock Sonar score 2/7 axes
Find similar shapesCompare2 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CTTH filings, in plain words
Are CTT Pharmaceutical insiders buying or selling CTTH?
In the 180 days to 2026-10-29, CTT Pharmaceutical insiders were net buyers, a net $4.6K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-29, CTT Pharmaceutical insiders were net buyers of CTTH, a net $4.6K across purchases and sales reported on Form 4 by 1 buyer. Each figure is counted from SEC and House filings as of 2026-10-29, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
